Newton Fund Evaluation: Final Report: Assessing Progress Towards Impact
Impact evaluation to assess the progress of the Newton Fund and recommendations for future research and innovation activities.
Daniela Rodriguez Rincon is a research leader at RAND Europe working in the areas of biosecurity and research and innovation policy. Her interest lies in pandemic preparedness and recovery, with a focus on pathogen detection capabilities and early warning systems, responsible innovation and cross-sector coordination. Rodriguez Rincon's work includes the evaluation of the COVID-19 Genomics Consortium (COG-UK), a study on public health laboratory preparedness during COVID-19, a study modeling HIV transmission and the impact of various policy interventions, an assessment of electronic health records for infectious disease surveillance, and development of tabletop exercises focused on surveillance and response capabilities. Rodriguez Rincon has also worked on the evaluation of research for development programmes, including the Global Challenges Research Fund, the Newton Fund and the MRC/DfID Concordat Agreement to support UK-led biomedical and public health research.
Rodriguez Rincon has also worked as an evaluation programme manager at the UK's Medical Research Council (MRC), as a research policy manager at the Association of the British Pharmaceutical Industry, and as an intern in the Department of Strategic Policy at the United Nations Joint Programme on HIV/AIDS (UNAIDS). Rincon holds a Ph.D. in medicine (microbiology) from the University of Cambridge and an M.Sc. in medical microbiology from the London School of Hygiene and Tropical Medicine.
Ph.D. in medicine (microbiology), University of Cambridge; M.Sc. in medical microbiology, London School of Hygiene and Tropical Medicine; B.Sc. in biology, Complutense University of Madrid
Spanish; English; French (basic)